Masimo (MASI) News & Sentiment

Masimo (MASI) has reached its highest point in 52 weeks, but can investors expect further growth ahead? We will examine the company's fundamentals for insights.

Masimo (MASI) shares have begun to rise and could keep increasing soon, based on positive changes in earnings forecasts.

No matter if you focus on value, growth, or momentum investing, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key features of the Zacks Premium research service.

Masimo (MASI) has strong growth characteristics that may enable it to significantly exceed market performance.

Masimo (MASI) has received a Zacks Rank #1 (Strong Buy) upgrade, indicating increased confidence in the company's potential earnings. This could lead to a rise in the stock price in the short term.

While the revenue and earnings per share (EPS) for Masimo (MASI) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.

Masimo (MASI) reported quarterly earnings of $1.80 per share, which is higher than the Zacks Consensus Estimate of $1.49 per share. This is an increase compared to earnings of $1.25 per share from the same period last year.

Masimo Corporation (NASDAQ:MASI) will hold its Q4 2024 Earnings Conference Call on February 25, 2025, at 4:30 PM ET. Participants from the company include Eli Kammerman, Katie Szyman, and Micah Young. The press release can be found on their website at www.masimo.com.

Masimo (MASI -0.69%), a company that offers noninvasive patient monitoring technology, announced its fourth-quarter earnings for 2024 on February 25, 2025. The results were mixed, showing strong performance in its main healthcare division, where revenue hit $601 million, exceeding analysts' predictions of $592 million.